Agencies like the US Food and Drug Administration speed the approval of some drugs to address urgent needs, but there are signs that the balance between safety and speed isn’t quite right
27 November 2019
HIGH ideals have a way of seeming like high hurdles when time is running out. If someone you love has been told they have just months to live, and there is a drug that might offer them even a few months more, it suddenly matters less that the drug isn’t cost-effective, or that it was approved on the basis of a small trial and its risks and benefits remain unclear. What matters is that it might buy precious time right now.
Did You See This CB Softwares?
37 SOFTWARE TOOLS... FOR $27!?Join Affiliate Bots Right Away
Such dilemmas are why the US Food and Drug Administration (FDA) and similar …